2015 annual financial data
Tempest Therapeutics 2015 Operating cash flow margin
Direct answer
Operating cash flow margin was -18,153.79%.
Operating income was -71,999,000 USD and net income was -73,219,000 USD.
Operating cash flow was -50,286,000 USD.
Get free Tempest Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 277,000 USD
- Operating income
- -71,999,000 USD
- Net income
- -73,219,000 USD
- Operating cash flow
- -50,286,000 USD